Skip to main content

Table 1 Patients’ demographic and clinical characteristics

From: 2D-perfusion angiography for intra-procedural endovascular treatment response assessment in chronic mesenteric ischemia: a feasibility study

Number of patients

39

Number of procedures

44

Number of treated arteries

49

Patients’ demographics

 

Median age (years ± standard deviation)

69.7 ± 9.8

Gender (n, %)

 

 Male

21 (54%)

 Female

18 (46%)

BMI (kg/m2 ± standard deviation)

19.3 ± 10.3

History of (n, %)

 

 Hypertension

38 (97%)

 Heavy smoking [> 20 pack years]

27 (69%)

 Diabetes

21 (53%)

 Coronary artery disease ± coronary bypass surgery

27 (69%)

 Stroke

2 (5%)

 Peripheral artery disease

28 (72%)

 Chronic kidney disease stage 1 (GFR > 90 mL/min/1.73m2)

7 (18%)

 Chronic kidney disease stage 2 (GFR 60–89 mL/min/1.73m2)

13 (33%)

 Chronic kidney disease stage 3 (GFR 30–59 mL/min/1.73m2)

12 (31%)

 Chronic kidney disease stage 4 + 5 (GFR < 29 mL/min/1.73m2 or dialysis)

7 (18%)

 Anemia (hemoglobin < 13.5 g/dl; hematocrit < 40%)

30 (77%)

Clinical characteristics

 

Clinical symptoms at presentation (n, %)

 

 Abdominal pain (postprandial)

39 (100%)

 Weight loss

36 (92%)

 Ischemic gastritis/colitis ± bleeding

15 (38%)

Immediate post-interventional pain decrease per procedure (n, %)

42 (95%)

Number of patients lost to follow-up after discharge (n, %)

11 (28%)

Weight gain per patient in follow-up (n, %)

21 (75%)

Recurrence of symptoms per patient in follow-up (n, %)

12 (43%)

Number of recorded deaths in follow-up (n, %)

7 (25%)

Bowel-infarction-related death in follow-up (n, %)

4 (14%)

  1. BMI body mass index, GFR glomerular filtration rate